Third Point's Q3 2025 letter details a 3.2% net return, driven by AI/semiconductor gains and new investments. It also ...

FDA announces major reforms to streamline biosimilar approvals, potentially saving Americans billions on prescription drug ...

A new study warns that rooftop solar’s emissions benefits are declining in the United States as power grids become less carbon intensive, underscoring the need to update how renewable impact is ...

Hey there! EFL Cup action ramps up on Wednesday as several Premier League heavy-hitters target a spot in the quarterfinals, ...

As clean energy grows, so do the limits of how it’s measured. A new Nature Climate Change study warns that rooftop solar’s ...

When it comes to the people most likely to buy his cars, Musk has made a lot of enemies. A study makes a plausible case that ...

AAM, the Biosimilars Council and NACDS commended the FDA for its announcement to make it faster and less costly to develop biosimilar medicines.

The edits were easy to miss: The description on the front of the Mr. Goodbar wrapper changed from “milk chocolate with ...

Q3 2025 Earnings Call November 3, 2025 5:00 AM ESTCompany ParticipantsInge Laudy - Manager of Investor RelationsLinde Jansen ...

MiCA deserves credit for imposing order on chaos, but its structure rests on a dangerous assumption: that proof-of-reserves equals proof-of-stability, argues Dr. Daniel D’Alvia. It does not.

"As a corporate plaintiff, Unlucky must have counsel to represent it and plead its case — and that means compensating counsel ...